Scott C. Kachlany
Fondatore presso Actinobac Biomed, Inc.
Posizioni attive di Scott C. Kachlany
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Actinobac Biomed, Inc.
 Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Fondatore | 17/07/2009 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/2009 | - | |
| Direttore/Membro del Consiglio | 01/01/2009 | - | |
| Corporate Officer/Principal | - | - | |
Leukovet
 Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Scott C. Kachlany
Precedenti posizioni note di Scott C. Kachlany
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 01/01/2003 | - |
Formazione di Scott C. Kachlany
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Leukovet
Leukovet Pharmaceuticals: MajorHealth Technology Leukovet develops peptide-based cancer therapeutics for the treatment of canine lymphoma, leukemia, and other immunological diseases. The company is based in New York, NY. The company was founded in 2019. The CEO is Sonia Gulati. | Health Technology |
- Borsa valori
- Insiders
- Scott C. Kachlany
- Esperienza